Inventiva (IVA) Notes Payables (2018 - 2025)
Inventiva's (IVA) quarterly Notes Payables came in at $6.3 billion in Q2 2025, up 101471.04% year-on-year from N/an in Q2 2024, and little changed quarter-over-quarter from $6.3 billion in Q4 2024.
Inventiva (IVA) Notes Payables (2018 - 2025) Analysis & Trends
Inventiva's Notes Payables history runs 8 years deep, the most recent figure standing at $6.3 billion for Q2 2025.
- On a quarterly basis, Notes Payables rose 101471.04% year-over-year to $6.3 billion in Q2 2025; TTM through Jun 2025 was $6.3 billion, a 101471.04% increase from a year earlier, with the FY2024 full-year figure at $6.3 billion, changed N/A from the prior year.
- Notes Payables was little changed at $6.3 billion in Q2 2025 per IVA's latest filing, from $6.3 billion in the prior quarter.
- Across five years, Notes Payables topped out at $6.3 billion in Q4 2024 and bottomed at $13268.6 in Q1 2021.
- The 5-year median for Notes Payables is $736.5 million (2023), against an average of $2.4 billion.
- Across the five-year window, Notes Payables jumped 32239824.15% in 2022 and tumbled 99.88% in 2023, its largest moves.
- Year by year, Notes Payables stood at $1.5 billion in 2021, then jumped by 270.63% to $5.4 billion in 2022, then sank by 99.88% to $6.4 million in 2023, then soared by 98318.24% to $6.3 billion in 2024, then dropped by 0.12% to $6.3 billion in 2025.
- Per Business Quant, the three latest IVA Notes Payables figures stand at $6.3 billion (Q2 2025), $6.3 billion (Q4 2024), and $6.2 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.26 Bn |
| Dec 31, 2024 | 6.27 Bn |
| Jun 30, 2024 | 6.17 Mn |
| Jun 30, 2023 | 6.37 Mn |
| Jun 30, 2022 | 5.44 Bn |
| Dec 31, 2021 | 1.47 Bn |
| Jun 30, 2021 | 16,859.80 |
| Mar 31, 2021 | 13,268.60 |
| Dec 31, 2020 | 21,461.22 |
| Jun 30, 2020 | 11.04 Mn |
| Dec 31, 2019 | 125,078.31 |
| Dec 31, 2018 | 172,350.86 |